G00035MO
| Organisms | Evidence |
|---|---|
| Rattus norvegicus (Norway rat) | |
| Homo sapiens (human) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| B4GALT4 | UDP-Gal |
|
p-Nitrophenyl |
|
p-Nitrophenyl | |
| B3GALT5 | UDP-Gal |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| B3GALT5 | UDP-Gal |
|
a-OpNp |
|
a-OpNp | |
| B4GALT1 | UDP-Gal |
|
O-glycan Synthesis |
|
O-glycan Synthesis |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| C1GALT1 | UDP-Gal |
|
O-glycan Synthesis | |
| B3GNT8 | UDP-GlcNAc |
|
core 3-pNp | |
| A4GNT | UDP-GlcNAc |
|
pNP | |
| B3GNT7 | UDP-GlcNAc |
|
core 3-pNp | |
| B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP(core 3) |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl 3b:b-dglc-HEX-1:5 4s:n-acetyl LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:3d(2+1)4n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 7140761 | Primary-structure determination of fourteen neutral oligosaccharides derived from bronchial-mucus glycoproteins of patients suffering from cystic fibrosis, employing 500-MHz 1H-NMR spectroscopy | Van Halbeek H | 1982 Sep |
|
| 7080930 | Isolation and characterisation of neutral oligosaccharides from human bronchial glycoproteins | Lamblin G | 1982 |
|
| 7372597 | Oligosaccharides of human bronchial glycoproteins. Neutral di- and trisaccharides isolated from a patient suffering from chronic bronchitis | Lamblin G | 1980 May 25 |
|
| 679218 | Structure of some oligosaccharides derived from rat-intestinal glycoproteins | Carlsson HE | 1978 Jul |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025